44.93MMarket Cap-527P/E (TTM)
1.6400High1.5700Low567.31KVolume1.6400Open1.6100Pre Close910.91KTurnover2.60%Turnover RatioLossP/E (Static)27.56MShares4.950052wk High2.52P/B35.62MFloat Cap1.240052wk Low--Dividend TTM21.85MShs Float190.5000Historical High--Div YieldTTM4.35%Amplitude1.2400Historical Low1.6050Avg Price1Lot Size
Fortress Biotech Stock Forum
- SEC Filing
Fortress Biotech Inc: FDA Accepted Nda Filing for Dfd-29 to Treat Inflammatory Lesions & Erythema of Rosacea in Adults; Pdufa Goal Date of Nov 4, 2024
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE
• Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
• Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...
$OptiNose (OPTN.US)$
when are the next date for $Checkpoint Therapeutics (CKPT.US)$ , $Fortress Biotech (FBIO.US)$ , and $Brainstorm Cell Therapeutics (BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
No comment yet